W
WAVEMAN · COMPANY
CYPH · Cypherpunk Technologies Inc.
> Ask across nine datasets ⌘K
LIVE
TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475
← ALL COMPANIES

CYPH

CYPHERPUNK TECHNOLOGIES INC.
PHARMA & BIOTECH · PHARMACEUTICAL PREPARATIONS · CIK 0001509745
FORM 144 · 1☆ WATCH
INSIDER NET · 180D
-$77.0K
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
30
13F, latest reported quarter
REVENUE GROWTH
0.0%
XBRL, annual
NET MARGIN
321.5%
CONVERSIONS · 180D
19
codes C/M, not in net · no price filed
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net -$77.0K over 180 days
-$34.4K over 90 days
more than 57% of Pharma & Biotech
CONGRESS
no member of Congress has reported trading it
FUNDS
30 funds added or opened last quarter
below 63% of Pharma & Biotech
REVENUE
+0.0% year over year
below 56% of Pharma & Biotech
MARGIN
321.5% net margin
more than 99% of Pharma & Biotech
BUYBACKS
no share repurchases reported
SHORT
6.8% of shares outstanding short · 6.1 days to cover · settled 2026-07-31
more than 64% of Pharma & Biotech
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
30 funds added or opened positions in the latest 13F quarter, of 48 holders.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN +720.3%
+720.3%12M
-4%+299%+603%+907%2025-092025-102025-122026-032026-052026-072026-09 2025-11-17 · Mirabelli Christopher sold $1.3M2025-11-17 · ONSI DOUGLAS E sold $1.3M2025-11-17 · Mirabelli Christopher sold $822.2K2025-11-17 · CAVANAUGH JAMES H sold $822.2K2025-11-17 · ONSI DOUGLAS E sold $822.2K2026-03-26 · Mirabelli Christopher sold $42.6K2026-08-26 · Dietz Thomas John sold $34.4K2026-08-26 · Dietz Thomas John filed to sell $32.3K
INSIDER SELLFORM 144
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
Insiders have filed to sell — before selling.
The record shows a net $77.0K sold by insiders over 180 days, 30 funds added last quarter, $32.3K in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, CYPHERPUNK TECHNOLOGIES INC. insiders sold a net $77.0K of stock across 7 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER
FILED
SHARES
VALUE
Dietz Thomas John
Director
SELL
2026-08-26
20,000.0
$34.4K
Mirabelli Christopher
Director
SELL
2026-03-26
60,000.0
$42.6K
Mirabelli Christopher
Director
SELL
2025-11-17
414,479.0
$1.3M
Mirabelli Christopher
Director
SELL
2025-11-17
261,840.0
$822.2K
CAVANAUGH JAMES H
Director
SELL
2025-11-17
261,840.0
$822.2K
7 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 2 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
VANGUARD CAPITAL MANAGEMENT LLC
3,887,574.0 sh
$2.4M
BlackRock, Inc.
2,622,823.0 sh
$1.6M
JANE STREET GROUP, LLC
1,701,926.0 sh
$1.0M
GEODE CAPITAL MANAGEMENT, LLC
1,173,737.0 sh
$718.8K
UBS Group AG
1,127,366.0 sh
$689.9K
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
Planned sales · Form 144
Filed before the sale — intent, not a trade
Dietz Thomas John
FILED 2026-08-26
$32.3K
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
Simplify Health Care ETF
$17.0K POSITION · AS OF 2026-03-31
0.0%
VANGUARD EXTENDED MARKET INDEX FUND
$438.0K POSITION · AS OF 2026-03-31
0.0%
Fidelity Extended Market Index Fund
$164.1K POSITION · AS OF 2026-02-28
0.0%
VANGUARD TOTAL STOCK MARKET INDEX FUND
$981.7K POSITION · AS OF 2026-03-31
0.0%
Fidelity Series Total Market Index Fund
$44.6K POSITION · AS OF 2026-02-28
0.0%
Fidelity Nasdaq Composite Index Fund
$10.1K POSITION · AS OF 2026-02-28
0.0%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
OPERATING INCOME$-41.1M$-70.1M$-87.0M$-56.8M
NET INCOME$5.0M$-68.0M$-81.0M$-54.6M
EPS (DILUTED)0.07-1.81-3.98-4.82
OPERATING CASH FLOW$-43.9M$-60.3M$-43.8M$-49.0M
CASH$14.0M$47.2M$70.6M$65.5M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-06 ALL SYSTEMS LIVE FOR MACHINES →